Search research articles
Contact Us
Filters
Showing results (11-20 of 27) with videos related to
Page
of 3
Sort By:
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
April 6, 2023
Pharmacogenetics testing (DPYD and UGT1A1) for fluoropyrimidine and irinotecan in routine clinical care: Perspectives of medical oncologists and oncology pharmacists
Sarah Glewis, Senthil Lingaratnam, Mei Krishnasamy, et al.
Clinical Sarcoma Research
|
December 11, 2013
Intra-patient dose escalation in Ewing's sarcoma treated with vincristine, doxorubicin, cyclophosphamide alternating with ifosfamide and etoposide: a retrospective review
Jeremy Lewin, Samantha Wieringa, Marnie Collins, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
May 21, 2026
Pre-emptive <i>DPYD</i> genotyping and fluoropyrimidine dose optimisation: Dose tolerance and survival in cancer patients
Sarah Glewis, Senthil Lingaratnam, Tim Spelman, et al.
Internal Medicine Journal
|
January 11, 2026
An Australasian survey of clinical practices in management of neutropenic fever in adult cancer patients 2023
Nikhil Singh, Senthil Lingaratnam, Gabrielle M Haeusler, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
January 29, 2022
A randomised controlled trial of clinical pharmacy intervention versus standard care to improve medication adherence in outpatients with head and neck cancer receiving radiotherapy
Sam Maleki, Sarah Glewis, Tsien Fua, et al.
Journal of Pharmaceutical Policy and Practice
|
August 23, 2024
Australian access to FDA-approved breakthrough therapy designation medicines: a 10-year review
Senthil Lingaratnam, Safeera Yasmeen Hussainy, Alexandra Murphy, et al.
British Journal of Cancer
|
March 20, 2022
A systematic review and meta-analysis of toxicity and treatment outcomes with pharmacogenetic-guided dosing compared to standard of care BSA-based fluoropyrimidine dosing
Sarah Glewis, Marliese Alexander, Muhammad N H Khabib, et al.
Clinical and Translational Science
|
May 3, 2024
A systematic review and meta-analysis of the impacts of germline pharmacogenomics on severe toxicity and symptom burden in adult patients with cancer
Senthil Lingaratnam, Mahek Shah, Joseph Nicolazzo, et al.
European Journal of Haematology
|
May 15, 2013
Late-onset Pneumocystis jirovecii pneumonia post-fludarabine, cyclophosphamide and rituximab: implications for prophylaxis
Gabrielle M Haeusler, Monica A Slavin, John F Seymour, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
June 16, 2023
Infective complications in cancer patients treated with subcutaneous versus intravenous trastuzumab and rituximab: An individual patient data meta-analysis
Marliese Alexander, Kim Jachno, Kelly-Anne Phillips, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 27) with videos related to
Sort By:
Page
of 3
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
April 6, 2023
Pharmacogenetics testing (DPYD and UGT1A1) for fluoropyrimidine and irinotecan in routine clinical care: Perspectives of medical oncologists and oncology pharmacists
Sarah Glewis, Senthil Lingaratnam, Mei Krishnasamy, et al.
Clinical Sarcoma Research
|
December 11, 2013
Intra-patient dose escalation in Ewing's sarcoma treated with vincristine, doxorubicin, cyclophosphamide alternating with ifosfamide and etoposide: a retrospective review
Jeremy Lewin, Samantha Wieringa, Marnie Collins, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
May 21, 2026
Pre-emptive <i>DPYD</i> genotyping and fluoropyrimidine dose optimisation: Dose tolerance and survival in cancer patients
Sarah Glewis, Senthil Lingaratnam, Tim Spelman, et al.
Internal Medicine Journal
|
January 11, 2026
An Australasian survey of clinical practices in management of neutropenic fever in adult cancer patients 2023
Nikhil Singh, Senthil Lingaratnam, Gabrielle M Haeusler, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
January 29, 2022
A randomised controlled trial of clinical pharmacy intervention versus standard care to improve medication adherence in outpatients with head and neck cancer receiving radiotherapy
Sam Maleki, Sarah Glewis, Tsien Fua, et al.
Journal of Pharmaceutical Policy and Practice
|
August 23, 2024
Australian access to FDA-approved breakthrough therapy designation medicines: a 10-year review
Senthil Lingaratnam, Safeera Yasmeen Hussainy, Alexandra Murphy, et al.
British Journal of Cancer
|
March 20, 2022
A systematic review and meta-analysis of toxicity and treatment outcomes with pharmacogenetic-guided dosing compared to standard of care BSA-based fluoropyrimidine dosing
Sarah Glewis, Marliese Alexander, Muhammad N H Khabib, et al.
Clinical and Translational Science
|
May 3, 2024
A systematic review and meta-analysis of the impacts of germline pharmacogenomics on severe toxicity and symptom burden in adult patients with cancer
Senthil Lingaratnam, Mahek Shah, Joseph Nicolazzo, et al.
European Journal of Haematology
|
May 15, 2013
Late-onset Pneumocystis jirovecii pneumonia post-fludarabine, cyclophosphamide and rituximab: implications for prophylaxis
Gabrielle M Haeusler, Monica A Slavin, John F Seymour, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
June 16, 2023
Infective complications in cancer patients treated with subcutaneous versus intravenous trastuzumab and rituximab: An individual patient data meta-analysis
Marliese Alexander, Kim Jachno, Kelly-Anne Phillips, et al.
Page
of 3